What is WVE's dilution risk score?

WVE has a latest available DilutionScore record of 33/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for WVE, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for WVE?

DilutionWatch tracks 25 SEC filing types for WVE including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect WVE shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For WVE, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for WVE tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for WVE. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

WVE Dilution Risk Score: 33/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

46

💰 Cash Runway

0

📊 Float Risk

40

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 0%

No significant dilution signals detected for WVE.

🔔 Track WVE — Get forecast alerts →

Market Data

Market Cap$1.27B

Shares Outstanding197.05M

Float90.11M

Cash$393.05M

Debt$15.71M

Short InterestN/A

Institutional Holdings

QoQ: ↓ 1.8% shares (2026Q1 vs prior)

237 institutional holders · 185.49M shares

#1 RA CAPITAL MANAGEMENT, L.P. 26.98M shares

#2 GSK plc 18.25M shares

#3 BlackRock, Inc. 14.12M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest16.40M

Days to Cover7.5

% of Float18.2%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31

xbrl XBRL CONVERTIBLE 2015-12-31

3 FORM3 2026-04-17

4 INSIDER TRANSACTION 2026-03-30

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual WVE Dilution Snapshot

Wave Life Sciences Ltd. (WVE) has a DilutionScore of 33/100, rated Medium dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for WVE: 3 on 2026-04-17; 3 on 2026-04-17; 4 on 2026-03-30.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education

→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

More Research for WVE

WVE FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.

WVE — Wave Life Sciences Ltd. Dilution Risk Tracker